Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crown Bioscience delivers industry-leading preclinical and translational research services in oncology and immuno-oncology. It offers the world’s largest commercially available patient-derived xenograft collection and over 600 tumor organoid models across more than twenty cancer types. The company has contributed to the development of multiple FDA-approved oncology drugs by providing advanced in vivo, in vitro, ex vivo, and in silico testing platforms for biotech/pharma partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crown Bioscience.